// App-Quantinova.ai

: SYNDECAN-1 AS A PROGNOSTIC BIOMARKER IN ACUTE MYELOID LEUKEMIA

Researchers

Presenter

  • Reham Alghandour

Principal Investigators

  • mohamed A. Ebrahim

  • mohammed MH. Al-Gayyar

  • Ziad Emarah

  • HF Ghazy

  • Sameh Shamaa

Medical Centers

  • Medical oncology,oncology center,Mansoura University,Mansoura,Egypt

  • Biochemistry, Faculty of Pharmacy, Mansoura University, Mansoura, Egypt

Locations

  • Egypt

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Acute myelocytic leukemia

  • Acute Leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Syndecan-1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved